• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York

    6/3/25 8:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care
    Get the next $VMD alert in real time by email

    LAFAYETTE, La., June 03, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced it will present at the East Coast IDEAS Investor Conference on Wednesday June 11, 2025 at The Westin Times Square in New York, NY. Viemed's presentation is scheduled to begin at 11:30am ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the Company's website: http://viemed.com/investors.

    ABOUT VIEMED HEALTHCARE, INC.

    Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at www.viemed.com.

    About IDEAS Investor Conferences

    The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to present their investment merits to an influential audience of investment professionals. Unlike traditional bank-sponsored events, IDEAS Investor Conferences are "SPONSORED BY INVESTORS. FOR INVESTORS." and for the benefit of regional investment communities. Conference sponsors collectively have more than $200 billion in assets under management and include: 1102 Partners, Adirondack Research and Management, Allianz Global Investors: NFJ Investment Group, Ariel Investments, Aristotle Capital Boston, Ascend Wealth Advisors, Barrow Hanley Mewhinney & Strauss, BMO Global Asset Management, Constitution Research & Management, Inc., Diamond Hill, First Wilshire Securities Management, Inc., Granahan Investment Management, Great Lakes Advisors, Greenbrier Partners Capital Management, LLC, Hodges Capital Management, Ironwood Investment Management, Keeley Teton Advisors, Luther King Capital Management, Marble Harbor Investment Counsel, North Star Investment Management, Perritt Capital Management, Punch & Associates, Shepherd Kaplan Krochuk, Westwood Holdings Group, Inc., and William Harris Investors.

    The IDEAS Investor Conferences are held annually and are produced by Three Part Advisors, LLC. Additional information about the events can be located at www.IDEASconferences.com.

    If interested in participating or learning more about the IDEAS conferences, please contact Lacey Wesley at (817) 769-2373 or [email protected].

    For further information, please contact:

    Investor Relations

    [email protected]

    Tripp Sullivan

    SCR Partners, LLC

    615-942-7077

    Trae Fitzgerald

    Chief Financial Officer

    Viemed Healthcare, Inc.

    337-504-3802



    Primary Logo

    Get the next $VMD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VMD

    DatePrice TargetRatingAnalyst
    11/3/2021$13.00 → $9.00Outperform
    RBC Capital
    More analyst ratings

    $VMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Viemed Healthcare Announces Share Repurchase Program

    LAFAYETTE, La., June 09, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that its Board of Directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase up to 1,976,441 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 31, 2025. The Company intends to repurchase Common Shares through open market purchases, block purchases o

    6/9/25 8:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York

    LAFAYETTE, La., June 03, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced it will present at the East Coast IDEAS Investor Conference on Wednesday June 11, 2025 at The Westin Times Square in New York, NY. Viemed's presentation is scheduled to begin at 11:30am ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the Company's website: http://viemed.com/investors. ABOUT VIEMED HEALTHCARE, INC. Viemed is an

    6/3/25 8:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces First Quarter 2025 Financial Results

    LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

    5/7/25 4:45:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Heltz Sabrina bought $19,977 worth of shares (2,820 units at $7.08), increasing direct ownership by 7% to 41,040 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    5/14/24 5:25:11 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    SEC Filings

    View All

    SEC Form S-8 filed by Viemed Healthcare Inc.

    S-8 - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/12/25 4:39:52 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 10-Q filed by Viemed Healthcare Inc.

    10-Q - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/6/25 5:06:51 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/6/25 5:04:31 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital reiterated coverage on Viemed Healthcare with a new price target

    RBC Capital reiterated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $9.00 from $13.00 previously

    11/3/21 9:01:34 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Royal Bank of Canada initiated coverage on Viemed Healthcare with a new price target

    Royal Bank of Canada initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

    3/11/21 8:08:09 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    RBC Capital initiated coverage on Viemed Healthcare with a new price target

    RBC Capital initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

    3/5/21 8:11:16 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Vice President of Sales Cambre Jerome sold $35,737 worth of shares (4,880 units at $7.32), decreasing direct ownership by 5% to 84,191 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/14/25 4:56:21 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    President Moore Michael sold $367,160 worth of shares (50,090 units at $7.33), decreasing direct ownership by 28% to 126,343 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/13/25 4:59:48 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Amendment: President Moore Michael returned $74,089 worth of shares to the company (8,948 units at $8.28), decreasing direct ownership by 5% to 176,433 units (SEC Form 4)

    4/A - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/13/25 4:57:02 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Viemed Healthcare Inc. (Amendment)

    SC 13D/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/15/24 9:27:58 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

    SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/15/24 9:27:32 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Viemed Healthcare Inc.

    SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/14/24 4:51:42 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Leadership Updates

    Live Leadership Updates

    View All

    Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

    LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment ("Lehan"), a healthcare company offering home medical equipment with specialties in respiratory care and women's health. "Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women's health and a deep commitment to community engagement," said Viemed Chief

    5/6/25 8:30:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health

    LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health ("EAH"), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama. "We are thrilled to join forces with the exceptional team at East Alabama Health to deliver best-in-class home medical services to their patients and expand Home

    4/2/24 9:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces Voting Results From Its Annual General Meeting of Shareholders

    LAFAYETTE, La., June 13, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced the voting results from its annual general meeting of shareholders held on June 13, 2023 (the "Meeting") in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 27,309,147, representing 71.33% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's m

    6/13/23 5:00:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Financials

    Live finance-specific insights

    View All

    Viemed Healthcare Announces First Quarter 2025 Financial Results

    LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

    5/7/25 4:45:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

    LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: (866) 682-6100 (US Toll-Free) +1 (862) 298-0702 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=0dOJVhdb Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com. ABOUT VIE

    4/22/25 4:30:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces Record 2024 Financial Results

    LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2024 reached a new Company record of $60.7 million representing an increase of $10.0 million, or 20%, over net revenues reported for the comparable quarter ended Decembe

    3/10/25 5:00:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care